Patenting Life
Tales from the Front Lines of Intellectual Property and the New Biology
Seiten
2025
Georgetown University Press (Verlag)
978-1-64712-519-6 (ISBN)
Georgetown University Press (Verlag)
978-1-64712-519-6 (ISBN)
- Noch nicht erschienen (ca. Januar 2025)
- Versandkostenfrei innerhalb Deutschlands
- Auch auf Rechnung
- Verfügbarkeit in der Filiale vor Ort prüfen
- Artikel merken
The story of the commercialization of biology by a pioneer in biotechnology patenting
Shortly after the emergence of genetic engineering in the 1970s, academic biologists were courted by venture capitalists and multinational companies. Researchers who understood the new biology of the time went from being merely curious about how the natural world functioned to realizing that they could profit from their newfound recognition. As they were inventing all sorts of newfangled organisms, biologists became acquainted with intellectual property.
Patenting Life provides insights into legal fights over patented microbes, virus-resistant crops, ownership of body parts, and the patents they engendered. Covering the early days of recombinant DNA science to the present, Goldstein shares cases from his own career and those of others involving blockbuster biological drugs, aseptic mosquitoes, genetically engineered cows, and CRISPR, the modern gene-editing technology that promises to vanquish congenital diseases such as sickle cell anemia. He also addresses the perceived downsides of the patent system: the high prices of drugs, international access to COVID-19 vaccines and other medicines, and the ascent of genetically modified crops.
Patenting Life will appeal to readers interested in science and technology and also those interested in laws promoting innovation.
Shortly after the emergence of genetic engineering in the 1970s, academic biologists were courted by venture capitalists and multinational companies. Researchers who understood the new biology of the time went from being merely curious about how the natural world functioned to realizing that they could profit from their newfound recognition. As they were inventing all sorts of newfangled organisms, biologists became acquainted with intellectual property.
Patenting Life provides insights into legal fights over patented microbes, virus-resistant crops, ownership of body parts, and the patents they engendered. Covering the early days of recombinant DNA science to the present, Goldstein shares cases from his own career and those of others involving blockbuster biological drugs, aseptic mosquitoes, genetically engineered cows, and CRISPR, the modern gene-editing technology that promises to vanquish congenital diseases such as sickle cell anemia. He also addresses the perceived downsides of the patent system: the high prices of drugs, international access to COVID-19 vaccines and other medicines, and the ascent of genetically modified crops.
Patenting Life will appeal to readers interested in science and technology and also those interested in laws promoting innovation.
Jorge Goldstein is a patent attorney trained in molecular biology who began his career on the ground floor of the biotechnology revolution forty years ago. He is a partner in Sterne, Kessler, Goldstein, and Fox, PLLC, and the author of the casebook US Biotechnology Patent Law (2023). He received a PhD in chemistry from Harvard University and a JD from George Washington University Law School.
Erscheint lt. Verlag | 2.1.2025 |
---|---|
Zusatzinfo | 18 Illustrations, black and white |
Verlagsort | Washington, DC |
Sprache | englisch |
Maße | 152 x 229 mm |
Themenwelt | Literatur ► Biografien / Erfahrungsberichte |
Sachbuch/Ratgeber ► Beruf / Finanzen / Recht / Wirtschaft ► Wirtschaft | |
Recht / Steuern ► EU / Internationales Recht | |
Recht / Steuern ► Wirtschaftsrecht ► Urheberrecht | |
Technik ► Umwelttechnik / Biotechnologie | |
ISBN-10 | 1-64712-519-7 / 1647125197 |
ISBN-13 | 978-1-64712-519-6 / 9781647125196 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich